688065 凯赛生物
已收盘 10-10 15:00:00
资讯
新帖
简况
凯赛生物（688065）披露以集中竞价交易方式回购公司股份的进展公告，10月09日股价上涨1.27%
证券之星 · 10-09 14:29
凯赛生物（688065）披露以集中竞价交易方式回购公司股份的进展公告，10月09日股价上涨1.27%
凯赛生物(688065.SH)拟推2025年员工持股计划
智通财经 · 09-29
凯赛生物(688065.SH)拟推2025年员工持股计划
凯赛生物最新公告：年产50万吨生物基戊二胺及90万吨生物基聚酰胺项目延期至2027年12月31日
证券之星 · 09-29
凯赛生物最新公告：年产50万吨生物基戊二胺及90万吨生物基聚酰胺项目延期至2027年12月31日
每周股票复盘：凯赛生物（688065）将召开2025年半年度业绩说明会
证券之星 · 09-20
每周股票复盘：凯赛生物（688065）将召开2025年半年度业绩说明会
凯赛生物（688065）披露召开2025年半年度业绩说明会公告，9月17日股价下跌0.13%
证券之星 · 09-17
凯赛生物（688065）披露召开2025年半年度业绩说明会公告，9月17日股价下跌0.13%
9月8日凯赛生物涨6.87%，博时上证科创板新材料ETF基金重仓该股
证券之星 · 09-08
9月8日凯赛生物涨6.87%，博时上证科创板新材料ETF基金重仓该股
凯赛生物涨6.87%，华安证券二周前给出“买入”评级
证券之星 · 09-08
凯赛生物涨6.87%，华安证券二周前给出“买入”评级
每周股票复盘：凯赛生物（688065）半年报净利增24.74%
证券之星 · 09-06
每周股票复盘：凯赛生物（688065）半年报净利增24.74%
每周股票复盘：凯赛生物（688065）取消监事会并修改章程，选举产生新董事会
证券之星 · 08-23
每周股票复盘：凯赛生物（688065）取消监事会并修改章程，选举产生新董事会
8月18日凯赛生物涨5.79%，博时上证科创板新材料ETF基金重仓该股
证券之星 · 08-18
8月18日凯赛生物涨5.79%，博时上证科创板新材料ETF基金重仓该股
凯赛生物（688065）2025年中报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 08-16
凯赛生物（688065）2025年中报简析：营收净利润同比双双增长，盈利能力上升
每周股票复盘：凯赛生物（688065）股东户数减少，业绩稳步增长
证券之星 · 08-16
每周股票复盘：凯赛生物（688065）股东户数减少，业绩稳步增长
凯赛生物：2025年半年度净利润约3.09亿元，同比增加24.74%
每日经济新闻 · 08-15
凯赛生物：2025年半年度净利润约3.09亿元，同比增加24.74%
凯赛生物：上半年净利3.09亿元 同比增24.74%
格隆汇 · 08-15
凯赛生物：上半年净利3.09亿元 同比增24.74%
每周股票复盘：凯赛生物（688065）召开股东大会并修改公司章程等
证券之星 · 08-09
每周股票复盘：凯赛生物（688065）召开股东大会并修改公司章程等
凯赛生物提名5位非独立董事候选人
财中社 · 08-01
凯赛生物提名5位非独立董事候选人
凯赛生物股价下跌2.1% 年内完成59亿元定增补充流动资金
金融界 · 07-31
凯赛生物股价下跌2.1% 年内完成59亿元定增补充流动资金
凯赛生物最新公告：2024年年度权益分派实施
证券之星 · 07-27
凯赛生物最新公告：2024年年度权益分派实施
今日共75只个股发生大宗交易，总成交16.83亿元
第一财经 · 07-22
今日共75只个股发生大宗交易，总成交16.83亿元
凯赛生物：目前月桂二酸产品主要为对外销售
每日经济新闻 · 07-15
凯赛生物：目前月桂二酸产品主要为对外销售
加载更多
公司概况
公司名称：
上海凯赛生物技术股份有限公司
所属行业：
化学纤维制造业
上市日期：
2020-08-12
主营业务：
上海凯赛生物技术股份有限公司的主营业务是新型生物基材料的研发、生产及销售。公司的主要产品是系列生物法长链二元酸（DC10-DC18）、生物基戊二胺、系列生物基聚酰胺、生物基连续纤维热塑型复合材料（Bio-PPACFRT）。
发行价格：
133.45
{"stockData":{"symbol":"688065","market":"SH","secType":"STK","nameCN":"凯赛生物","latestPrice":52.59,"timestamp":1760079600000,"preClose":52.7,"halted":0,"volume":3875484,"delay":0,"changeRate":-0.0021,"floatShares":583000000,"shares":721000000,"eps":0.7628,"marketStatus":"已收盘","change":-0.11,"latestTime":"10-10 15:00:00","open":52.57,"high":52.91,"low":51.93,"amount":203000000,"amplitude":0.0186,"askPrice":52.59,"askSize":61,"bidPrice":52.58,"bidSize":28,"shortable":0,"etf":0,"ttmEps":0.7628,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1760319000000},"marketStatusCode":5,"adr":0,"adjPreClose":52.7,"symbolType":"stock_kcb","openAndCloseTimeList":[[1760059800000,1760067000000],[1760072400000,1760079600000]],"highLimit":57.97,"lowLimit":47.43,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":721289794,"isCdr":false,"pbRate":2.17,"roa":"--","peRate":68.943367,"roe":"2.11%","epsLYR":0.84,"committee":-0.480122,"marketValue":37933000000,"turnoverRate":0.0066,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-10-13。","afterMarket":{"amount":0,"volume":0,"close":52.59,"buyVolume":0,"sellVolume":0,"time":1760081637768,"indexStatus":"已收盘 10-10 15:30:00","preClose":52.7},"floatMarketCap":30680000000},"requestUrl":"/m/hq/s/688065","defaultTab":"news","newsList":[{"id":"2574166636","title":"凯赛生物（688065）披露以集中竞价交易方式回购公司股份的进展公告，10月09日股价上涨1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574166636","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574166636?lang=zh_cn&edition=full","pubTime":"2025-10-09 22:29","pubTimestamp":1760020155,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘，凯赛生物报收于52.7元，较前一交易日上涨1.27%，最新总市值为380.12亿元。近日，凯赛生物发布关于以集中竞价交易方式回购公司股份的进展公告。公告显示，证券代码：688065，证券简称：凯赛生物，公告编号：2025-057。上海凯赛生物技术股份有限公司于2024年10月21日召开董事会审议通过回购股份方案，回购期限为2024年10月21日至2025年10月20日，拟回购金额为1,000万元至2,000万元，用于员工持股计划或股权激励，回购价格不超过67元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900034482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2571334231","title":"凯赛生物(688065.SH)拟推2025年员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2571334231","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571334231?lang=zh_cn&edition=full","pubTime":"2025-09-29 22:05","pubTimestamp":1759154756,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯赛生物 披露2025年员工持股计划(草案)，参加对象包括公司董事、高级管理人员、公司中层管理人员、技术(业务)骨干。员工持股计划拟持有的标的股票数量不超过130.00万股，约占员工持股计划草案公布时公司股本总额的0.18%。为满足公司可持续发展的需要及不断吸引和留住优秀人才，员工持股计划拟预留15.00万股作为预留份额，占员工持股计划股票总数的11.54%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350908.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2571317103","title":"凯赛生物最新公告：年产50万吨生物基戊二胺及90万吨生物基聚酰胺项目延期至2027年12月31日","url":"https://stock-news.laohu8.com/highlight/detail?id=2571317103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571317103?lang=zh_cn&edition=full","pubTime":"2025-09-29 21:40","pubTimestamp":1759153210,"startTime":"0","endTime":"0","summary":"凯赛生物(688065.SH)公告称，公司于2025年9月29日召开第三届董事会第二次会议，审议通过了《关于部分募投项目延期的议案》，同意公司对募投项目“年产50万吨生物基戊二胺及90万吨生物基聚酰胺项目”达到预定可使用状态的时间进行延期。调整前预计2025年12月31日完成，现调整为2027年12月31日。此次延期是基于项目所在园区配套基础设施和投产条件尚未完善，符合相关法律法规和规范性文件的要求，不会对公司正常经营产生重大不利影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900034773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2569106243","title":"每周股票复盘：凯赛生物（688065）将召开2025年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2569106243","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569106243?lang=zh_cn&edition=full","pubTime":"2025-09-21 02:10","pubTimestamp":1758391823,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，凯赛生物报收于51.88元，较上周的54.14元下跌4.17%。本周，凯赛生物9月15日盘中最高价报54.51元。凯赛生物当前最新总市值374.21亿元，在化学制品板块市值排名6/169，在两市A股市值排名479/5153。本周关注点公司公告汇总：凯赛生物将于2025年09月25日召开2025年半年度业绩说明会。投资者可于2025年09月18日至09月24日16:00前通过上证路演中心“提问预征集”栏目或公司邮箱cathaybiotech_info@cathaybiotech.com提交问题。说明会期间，投资者可通过上证路演中心在线参与并提问。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2568492935","title":"凯赛生物（688065）披露召开2025年半年度业绩说明会公告，9月17日股价下跌0.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568492935","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568492935?lang=zh_cn&edition=full","pubTime":"2025-09-17 22:23","pubTimestamp":1758119000,"startTime":"0","endTime":"0","summary":"截至2025年9月17日收盘，凯赛生物报收于53.47元，较前一交易日下跌0.13%，最新总市值为385.67亿元。公司近日发布公告称，上海凯赛生物技术股份有限公司将于2025年09月25日（星期四）14:00-15:00通过上证路演中心以网络互动方式召开2025年半年度业绩说明会，介绍公司2025年半年度经营成果、财务状况等。投资者可于2025年09月18日至09月24日16:00前通过上证路演中心“提问预征集”栏目或公司邮箱cathaybiotech_info@cathaybiotech.com提交问题。说明会期间，投资者可通过上证路演中心在线参与并提问。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700040414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2565538501","title":"9月8日凯赛生物涨6.87%，博时上证科创板新材料ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2565538501","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565538501?lang=zh_cn&edition=full","pubTime":"2025-09-08 16:23","pubTimestamp":1757319837,"startTime":"0","endTime":"0","summary":"证券之星消息，9月8日凯赛生物涨6.87%创60日新高，收盘报55.69元，换手率1.44%，成交量8.41万手，成交额4.57亿元。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为博时基金的博时上证科创板新材料ETF。博时上证科创板新材料ETF目前规模为2.56亿元，最新净值0.7664，较上一交易日上涨6.08%，近一年上涨79.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090800020574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["516480","512880","688065","510300","BK0208","512510","159967","000300.SH","510880","515890","159982","399006","399001","399300","000905.SH","000001.SH","000688.SH"],"gpt_icon":0},{"id":"2565583501","title":"凯赛生物涨6.87%，华安证券二周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2565583501","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565583501?lang=zh_cn&edition=full","pubTime":"2025-09-08 16:23","pubTimestamp":1757319828,"startTime":"0","endTime":"0","summary":"今日凯赛生物涨6.87%，收盘报55.69元。2025年8月25日，华安证券研究员王强峰,刘天其发布了对凯赛生物的研报《25Q2业绩持续增长，生物基PA商业化放量在即》，该研报对凯赛生物给出“买入”评级。研报中预计公司2025-2027年归母净利润分别为6.86、8.49、11.22亿元，同比增速为40.2%、23.8%、32.1%。维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为长城证券的王彤。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090800020569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","600909"],"gpt_icon":0},{"id":"2565854503","title":"每周股票复盘：凯赛生物（688065）半年报净利增24.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565854503","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565854503?lang=zh_cn&edition=full","pubTime":"2025-09-07 07:04","pubTimestamp":1757199858,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，凯赛生物报收于52.11元，较上周的53.03元下跌1.73%。本周，凯赛生物9月1日盘中最高价报54.68元。凯赛生物当前最新总市值375.86亿元，在化学制品板块市值排名6/169，在两市A股市值排名459/5152。本周关注点来自公司公告汇总：截至2025年8月31日，凯赛生物累计回购股份230,366股，支付金额10,497,716.71元。业绩披露要点2025年上半年，公司营业收入为167,076.79万元，同比增长15.68%；归属于上市公司股东的净利润为30,866.71万元，同比增长24.74%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700001508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2561258925","title":"每周股票复盘：凯赛生物（688065）取消监事会并修改章程，选举产生新董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2561258925","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561258925?lang=zh_cn&edition=full","pubTime":"2025-08-24 04:50","pubTimestamp":1755982221,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘，凯赛生物报收于51.28元，较上周的49.08元上涨4.48%。本周，凯赛生物8月18日盘中最高价报52.8元。凯赛生物当前最新总市值369.88亿元，在化学制品板块市值排名5/169，在两市A股市值排名458/5152。本周关注点公司公告汇总：凯赛生物取消监事会并修改公司章程，选举产生新一届董事会成员公司公告汇总会议于2025年8月18日召开，由董事长XIUCAI LIU博士主持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400000889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2560977269","title":"8月18日凯赛生物涨5.79%，博时上证科创板新材料ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2560977269","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560977269?lang=zh_cn&edition=full","pubTime":"2025-08-18 16:22","pubTimestamp":1755505324,"startTime":"0","endTime":"0","summary":"证券之星消息，8月18日凯赛生物涨5.79%创60日新高，收盘报51.92元，换手率1.52%，成交量8.85万手，成交额4.59亿元。重仓凯赛生物的公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为博时基金的博时上证科创板新材料ETF。博时上证科创板新材料ETF目前规模为2.56亿元，最新净值0.7067，较上一交易日上涨3.44%，近一年上涨62.16%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081800021523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399006","000905.SH","000300.SH","159967","399001","000688.SH","399300","512880","510880","515890","516480","688065","BK0208","512510","159982","000001.SH","510300"],"gpt_icon":0},{"id":"2560926651","title":"凯赛生物（688065）2025年中报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2560926651","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560926651?lang=zh_cn&edition=full","pubTime":"2025-08-17 06:02","pubTimestamp":1755381772,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期凯赛生物发布2025年中报。截至本报告期末，公司营业总收入16.71亿元，同比上升15.68%，归母净利润3.09亿元，同比上升24.74%。按单季度数据看，第二季度营业总收入8.95亿元，同比上升17.8%，第二季度归母净利润1.72亿元，同比上升20.77%。本报告期凯赛生物盈利能力上升，毛利率同比增幅8.4%，净利率同比增幅0.64%。持有凯赛生物最多的基金为博时上证科创板新材料ETF，目前规模为2.56亿元，最新净值0.7067，较上一交易日上涨3.44%，近一年上涨62.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700001063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065"],"gpt_icon":0},{"id":"2560925076","title":"每周股票复盘：凯赛生物（688065）股东户数减少，业绩稳步增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2560925076","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560925076?lang=zh_cn&edition=full","pubTime":"2025-08-17 04:43","pubTimestamp":1755376989,"startTime":"0","endTime":"0","summary":"截至2025年8月15日收盘，凯赛生物报收于49.08元，较上周的48.85元上涨0.47%。本周，凯赛生物8月11日盘中最高价报49.38元。业绩披露要点：2025年中报显示，凯赛生物主营收入16.71亿元，同比增长15.68%；归母净利润3.09亿元，同比增长24.74%。公司公告汇总：凯赛生物作废2020年和2022年限制性股票激励计划部分已授予尚未归属的限制性股票，合计83.524万股。股本股东变化近日凯赛生物披露，截至2025年6月30日公司股东户数为1.17万户，较3月31日减少346.0户，减幅为2.87%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700000784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2559917537","title":"凯赛生物：2025年半年度净利润约3.09亿元，同比增加24.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559917537","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559917537?lang=zh_cn&edition=full","pubTime":"2025-08-15 21:52","pubTimestamp":1755265920,"startTime":"0","endTime":"0","summary":"凯赛生物（SH 688065，收盘价：49.08元）8月15日晚间发布半年度业绩报告称，2025年上半年营业收入约16.71亿元，同比增加15.68%；归属于上市公司股东的净利润约3.09亿元，同比增加24.74%；基本每股收益0.47元，同比增加11.9%。（文章来源：每日经济新闻）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-08-15/doc-infmapwu1274026.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-08-15/doc-infmapwu1274026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688065"],"gpt_icon":0},{"id":"2559121619","title":"凯赛生物：上半年净利3.09亿元 同比增24.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559121619","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559121619?lang=zh_cn&edition=full","pubTime":"2025-08-15 21:49","pubTimestamp":1755265756,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2558072507","title":"每周股票复盘：凯赛生物（688065）召开股东大会并修改公司章程等","url":"https://stock-news.laohu8.com/highlight/detail?id=2558072507","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558072507?lang=zh_cn&edition=full","pubTime":"2025-08-10 03:55","pubTimestamp":1754769312,"startTime":"0","endTime":"0","summary":"截至2025年8月8日收盘，凯赛生物报收于48.85元，较上周的47.77元上涨2.26%。本周，凯赛生物8月6日盘中最高价报49.88元。本周关注点公司公告汇总：凯赛生物将于2025年8月18日召开第二次临时股东大会，审议取消监事会等多项议案2025年第二次临时股东大会会议资料：选举第三届董事会成员，包括非独立董事和独立董事候选人公司公告汇总凯赛生物计划于2025年8月18日14:00召开2025年第二次临时股东大会，会议将采用现场投票和网络投票相结合的方式。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081000000709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2556818090","title":"凯赛生物提名5位非独立董事候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2556818090","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556818090?lang=zh_cn&edition=full","pubTime":"2025-08-01 19:33","pubTimestamp":1754048013,"startTime":"0","endTime":"0","summary":"8月1日，凯赛生物（688065）发布公告，关于董事会换届选举的事项。公司第二届董事会任期即将届满，决定开展第三届董事会的选举工作。根据公告，第三届董事会将由5名非独立董事、3名独立董事和1名职工代表董事组成，职工代表董事由职工代表大会选举产生。经公司董事会提名委员会对第三届董事会董事候选人资格审查，同意提名XIUCAI LIU（刘修才）、邓伟栋、卢奕扬、臧慧卿、杨晨为非独立董事候选人，同意提名吴向阳、商建刚、连立帅为独立董事候选人。2025年一季度，凯赛生物实现收入7.76亿元，归母净利润1.37亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801193351972cc25d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801193351972cc25d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2556300628","title":"凯赛生物股价下跌2.1% 年内完成59亿元定增补充流动资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2556300628","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556300628?lang=zh_cn&edition=full","pubTime":"2025-08-01 02:28","pubTimestamp":1753986498,"startTime":"0","endTime":"0","summary":"凯赛生物7月31日报收48.10元，较前一交易日下跌2.1%。盘中最高触及49.12元，最低下探47.90元，成交金额1.56亿元。作为科创板上市公司，凯赛生物专注于合成生物学领域的技术创新和产业化应用。公开信息显示，凯赛生物今年已完成59亿元规模的定向增发，募集资金全部用于补充流动资金和偿还银行贷款。此次定增规模超过公司IPO融资金额，在年内A股市场40亿元以上规模的定增案例中位居前列。7月31日主力资金净流入904.16万元，占流通市值比例为0.03%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080102375994c6e64d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080102375994c6e64d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2554710466","title":"凯赛生物最新公告：2024年年度权益分派实施","url":"https://stock-news.laohu8.com/highlight/detail?id=2554710466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554710466?lang=zh_cn&edition=full","pubTime":"2025-07-27 17:10","pubTimestamp":1753607400,"startTime":"0","endTime":"0","summary":"凯赛生物(688065.SH)公告称，公司2024年年度利润分配方案已获股东大会审议通过，将以721,289,794股扣除回购专用账户的股份为基数，向全体股东每10股派发现金红利4元（含税），不送红股、不以资本公积转增股本。合计拟派发现金红利287,579,451.60元（含税）。股权登记日为2025年7月31日，除权（息）日和现金红利发放日均为2025年8月1日。公司回购专用证券账户中的股份不参与利润分配。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072700006162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2553234469","title":"今日共75只个股发生大宗交易，总成交16.83亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553234469","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553234469?lang=zh_cn&edition=full","pubTime":"2025-07-22 17:38","pubTimestamp":1753177111,"startTime":"0","endTime":"0","summary":"今日A股共75只个股发生大宗交易，总成交16.83亿元，其中上汽集团、齐鲁银行、安靠智电成交额居前，成交额依次为1.57亿元、1.46亿元、8640万元。成交价方面，共14只股票平价成交，4只股票溢价成交，57只股票折价成交；ST纳川、民生银行、晶华微溢价率居前，溢价率依次为2.53%、0.95%、0.18%；铂科新材、凯赛生物、强瑞技术折价率居前，折价率依次为22.53%、21.36%、19.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722173832954cb500&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722173832954cb500&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","688065","BK0014","BK0188","BK0187","BK0015","BK0017","BK0020","BK0264","BK0196","600104","BK0183","BK0028","BK0175","BK0184"],"gpt_icon":0},{"id":"2551161136","title":"凯赛生物：目前月桂二酸产品主要为对外销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2551161136","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551161136?lang=zh_cn&edition=full","pubTime":"2025-07-15 16:36","pubTimestamp":1752568607,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：请问凯赛生物今年生产的月桂二酸里面，预计大概有多少比例打算自用？会超过50%吗？凯赛生物（688065.SH）7月15日在投资者互动平台表示，公司的DC12（月桂二酸）可用于制备聚酰胺612、高级香料、高档润滑油、高档防锈剂、高级粉末涂料、热熔胶、合成纤维以及其他聚合物。目前公司生产的月桂二酸产品主要为对外销售。（记者 胡玲）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507151637539543376b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507151637539543376b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1760139177897,"stockEarnings":[{"period":"1week","weight":0.0106},{"period":"1month","weight":-0.0267},{"period":"3month","weight":0.1329},{"period":"6month","weight":0.0552},{"period":"1year","weight":0.0549},{"period":"ytd","weight":0.3668}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":0.0222},{"period":"3month","weight":0.1102},{"period":"6month","weight":0.2034},{"period":"1year","weight":0.1802},{"period":"ytd","weight":0.1627}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海凯赛生物技术股份有限公司","boardCode":"AI0028","boardName":"化学纤维制造业","stockholders":"11714人(较上一季度减少2.87%)","perCapita":"49801股","listingDate":"2020-08-12","address":"上海市浦东新区中国(上海)自由贸易试验区蔡伦路1690号5幢4楼","registeredCapital":"72128万元","survey":" 上海凯赛生物技术股份有限公司的主营业务是新型生物基材料的研发、生产及销售。公司的主要产品是系列生物法长链二元酸（DC10-DC18）、生物基戊二胺、系列生物基聚酰胺、生物基连续纤维热塑型复合材料（Bio-PPACFRT）。","listedPrice":133.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯赛生物(688065)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯赛生物,688065,凯赛生物股票,凯赛生物股票老虎,凯赛生物股票老虎国际,凯赛生物行情,凯赛生物股票行情,凯赛生物股价,凯赛生物股市,凯赛生物股票价格,凯赛生物股票交易,凯赛生物股票购买,凯赛生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯赛生物(688065)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}